IL1A: a novel prognostic biomarker and potential therapeutic target for renal clear cell carcinoma
In conclusion, our study demonstrates the potential role of IL 1A in the prognosis of RCC and establishes a theoretical foundation for subsequent <i>in vivo</i> and clinical investigations.
Authors
- Tonghui Ma (ORCID: https://orcid.org/0000-0002-5414-0522)
- X. Meng
- Jun Li (ORCID: https://orcid.org/0000-0003-4353-5761)
- Yuan Zhang (ORCID: https://orcid.org/0000-0002-1624-3715)
- Cheng Huang (ORCID: https://orcid.org/0009-0006-9407-1097)
- Jin Zeng (ORCID: https://orcid.org/0000-0001-9962-8460)
Institutions
- Anhui Medical University (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/or.2025.061978
- Citations
- 2
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04